Engineered Fibrillar ECM Networks for 3D Tumor Modeling
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for studying tumor progression and metastasis are hindered by the complexity of native hyaluronan synthesis and degradation, making it challenging to isolate the role of hyaluronan in tumor tissues, and existing biomaterial-based approaches fail to replicate the physiological morphology and dimensionality of native extracellular matrices.
Innovation Solution
Development of engineered three-dimensional extracellular matrices (ECMs) comprising fibronectin and hyaluronic acid, with controlled disulfide conjugation strategies to create fibrillar networks that mimic tumor-associated ECMs, allowing for controlled presentation and study of hyaluronan's role in tumor cell regulation.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of manufacture
If biomaterial-based approaches using hydrogels are used to study tumor-associated HA, then it is easier to control and characterize hyaluronan, but the systems fail to replicate the physiological morphology, dimensionality, and ECM complexity of native tissues
Solution Approach 1:
The patent combines hydrogel matrices with suspended fibrillar networks of extracellular matrix proteins (fibronectin, collagen) and glycans (hyaluronan) to create a composite material system. This composite structure integrates the ease of control and characterization of hydrogels with the physiological morphology and complexity of native ECM, allowing researchers to study tumor cell behavior in a more realistic three-dimensional environment while maintaining experimental controllability
Solution Approach 2:
The invention transitions from two-dimensional hydrogel surfaces to three-dimensional scaffold structures with suspended fibrils that extend through the volume of the material. This dimensional enhancement recreates the spatial complexity and morphological features of native extracellular matrix, enabling more accurate modeling of tumor cell interactions with the ECM in three-dimensional space
2Adaptability or versatility
If cell-based models are used to study hyaluronan in tumor tissue, then the complex nature of native HA synthesis and degradation can be studied, but it becomes challenging to isolate the role of HA in tumor cell behavior
Solution Approach 1:
The patent extracts and isolates hyaluronan and other ECM components from the complex cellular environment into controlled biomaterial constructs. By suspending defined concentrations and types of hyaluronan within the fibrillar network, researchers can study the specific effects of HA on tumor cell behavior independent of cellular synthesis and degradation processes, while still maintaining the ability to investigate complex HA-protein interactions
Solution Approach 2:
The engineered ECM acts as an intermediary system between complete cell-based models and simplified hydrogel models. It provides a controllable environment where hyaluronan's role can be isolated and studied through systematic variation of HA concentration, molecular weight, and crosslinking, while still supporting tumor cell growth and enabling observation of complex cell-ECM interactions
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The engineered ECMs support three-dimensional cellular growth, promote tumor-mimetic phenotypes, and enable the investigation of hyaluronan's role in tumor cell fate and metastasis, providing a controlled environment to study the cooperative and conflicting roles of fibronectin and hyaluronan in regulating tumor cell behavior.
Implementation Method 1
controlled disulfide conjugation strategies to create fibrillar networks
Data Source
AI summary
Synthetic cellular support systems in the form of engineered extracellular matrices are provided. The cellular support system may include a three-dimensional scaffold structure comprising at least one void. At least one suspended fibril spans across the at least one void in the three-dimensional scaffold structure. The suspended fibril comprises at least one extracellular matrix protein, such as fibronectin, and at least one glycan, such as a hyaluronic acid. The suspended fibril is capable of supporting cells and promoting three-dimensional cellular growth. In various aspects, a plurality of suspended fibrils may span the void to form a three-dimensional suspended fibrillar network.